The Nasdaq 100 (^NDX) is where investors find some of the most innovative and disruptive companies shaping the future. A select few continue to execute at a high level, growing their market dominance and delivering strong returns.

Justin Pope has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends ASML, Alphabet, Nvidia, Palantir Technologies, and Taiwan Semiconductor Manufacturing. The Motley Fool has a disclosure policy.

(Reuters) -Wall Street futures held steady on Friday as investors took a breather following record closes for the S&P 500 and the Nasdaq in the previous session and awaited clarity on trade negotiations ahead of next week's tariff deadline.

Palantir is taking the high ground in the artificial intelligence (AI) software revolution. The company has delivered nine consecutive quarters of accelerating revenue and profit growth thanks to its state-of-the-art AI solutions,

Two companies have recently seen their stock prices head higher on optimism about the future growth in AI spending. Palantir Technologies (NASDAQ: PLTR) shares are up 93% from their April low, as of this writing. Taiwan Semiconductor Manufacturing (NYSE: TSM) is up 67% in that same period.

US stocks end mostly up on more solid earnings. Nasdaq and S&P 500 hit records. Results from so-called Magnificent 7 tech stocks could set the tone.

Palantir's expansion into commercial markets has boosted its business. The stock has been on a tear since the start of 2024. Palantir's valuation is sky-high.

Still, XRP's growth curve is undeniably gentler than Strategy's, and it's possible that its millionaire-maker trajectory is largely in the past rather than the future. Ripple needs to roll out additional services, court more governments and regulators, and withstand political pushback if it happens again.

Dow Jones is losing ground as traders take profits near historic highs. Nike, which is up by 3.8%, is the biggest gainer in the Dow Jones index today. The stock rallied as JP Morgan upgraded Nike from Neutral to Overweight.

--The Nasdaq Stock Market announced today that it will delist the common stock and warrants of NKGen Biotech, Inc. NKGen Biotech, Inc.’ s securities were suspended on March 5, 2025 and have not ...